Developmental Programming: Maternal Hypercholesterolem and Immunity Influence Susceptibility to Atherosclerosis

Nutrition Reviews

Volumn 65, Issue SUPPL.3, 2007, Pages

  Palinski, Wulf ^a   Yamashita, Tomoya ^b   Freigang, Stefan ^c   Napoli, Claudio ^d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b KOBE UNIVERSITY   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adaptive immunity; Atherosclerosis; Developmental programming; Immunomodulation; Inflammation; Maternal hypercholesterolemia; Oxidative stress

Indexed keywords

ATHEROSCLEROSIS; DISEASE PREDISPOSITION; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; HYPERCHOLESTEROLEMIA; NUTRITIONAL STATUS; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; REVIEW;

ATHEROSCLEROSIS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MATERNAL-FETAL EXCHANGE; NUTRITIONAL STATUS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 39649111551     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2007.tb00360.x     Document Type: Article

References (34)

1. Barker DJ, Winter PD, Osmond C, Margetts B, Sim-monds SJ. Weight in infancy and death from isch-aemic heart disease. Lancet 1989;2:577-580.
2. Fall CH, Vijayakumar M, Barker DJ, Osmond C, Duggleby S. Weight in infancy and prevalence of coronary heart disease in adult life. BMJ 1995;310:17-19.
3. Barker DJ, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 1990;301:259-262.
4. Barker DJ, Osmond C, Golding J, Kuh D, Wads-worth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298:564-567.
5. Fall CH, Osmond C, Barker DJ, et al. Fetal and infant growth and cardiovascular risk factors in women. BMJ 1995;310:428-432.
6. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996;94:3246-3250.
7. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH. Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype BMJ 1994;308:942-945.
8. Robinson JS, Moore VM, Owens JA, McMillen IC. Origins of fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2000;92:13-19.
9. Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health 2005;95:1545-1551.
10. Henriksen T, Clausen T. The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations. Acta Obstet Gynecol Scand 2002;81:112-114.
11. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006;83:456S-460S.
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
13. Napoli C, D'Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterol-emia. Intimal accumulation of low density lipopro-tein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-2690.
14. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999;354:1234-1241.
15. Napoli C, Witztum JL, Calara F, de Nigris F, Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res 2000;87:946-952.
16. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-1376.
17. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91:2488-2496.
18. Steinberg D. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-1071.
19. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001;7:48-52.
20. Napoli C, de Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 2001;82:674-682.
21. Napoli C, Quehenberger O, De Nigris F, Abete P, Glass CK, Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 2000;14:1996-2007.
22. Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-1262.
23. Palinski W, D'Armiento FP, Witztum JL, et al. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res 2001;89:991-996.
24. Napoli C, de Nigris F, Welch JS, et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 2002;105:1360-1367.
25. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002;16:1348-1360.
26. Binder CJ, Chang MK, Shaw PX, et al. Innate and acquired immunity in atherogenesis. Nat Med 2002;8:1218-1226.
27. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281-291.
28. Horkko S, Miller E, Dudl E, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996;98:815-825.
29. Palinski W, Miller E, Witztum JL Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 1995;92:821-825.
30. Ameli S, Hultgardh-Nilsson A, Regnstrom J, et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercho-lesterolemic rabbits. Arterioscler Thromb Vasc Biol 1996;16:1074-1079.
31. Nilsson J, Calara F, Regnstrom J, et al. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1997;30:1886-1891.
32. Freigang S, Horkko S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 1998;18:1972-1982.
33. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hans-son GK. LDL immunization induces T-cell-depen-dent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:108-114.
34. Yamashita T, Freigang S, Eberle C, et al. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res 2006;99:e51-64.